查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1998699

冠狀動脈支架市場機會、成長要素、產業趨勢分析及2026-2035年預測。

Coronary Stents Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，全球冠狀動脈支架市場價值將達到 67 億美元，並有望以 8.2% 的複合年成長率成長，到 2035 年達到 146 億美元。

冠狀動脈支架市場-IMG1

市場成長主要受心血管疾病盛行率上升、人口老化、支架技術進步、微創手術日益普及等因素所驅動。冠狀動脈支架是一種管狀醫療設備，植入狹窄或阻塞的冠狀動脈，在維持血管通暢性、改善血流和預防心肌梗塞方面發揮重要作用。冠狀動脈疾病是全球主要死因之一，其發生率的不斷上升正在推動市場需求。藥物釋放型支架、生物可吸收支架和無聚合物支架等技術創新透過最大限度地減少血管再阻塞和血栓症形成，改善了長期治療效果。患者意識的提高、臨床醫生信心的增強以及血管重建手術的擴展進一步推動了支架的普及。藥物釋放型支架和生物可分解支架的普及以及以患者為中心的治療方法等趨勢正在塑造全球重組行業的成長。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 67億美元
預計金額 146億美元
複合年成長率 8.2%

預計到2025年，藥物釋放型支架市場佔有率將達到84.8%，這主要得益於其能夠最大限度地減少血管再阻塞、改善患者長期預後並支持微創治療。藥物釋放型支架透過釋放藥物來抑制組織過度增生，與裸金屬支架相比，可帶來更優的長期療效，這也推動了其在臨床實踐中的廣泛應用。

預計2035年，鈷鉻合金支架市場規模將達75億美元。鈷鉻合金支架具有高抗張強度和耐久性，即使在動脈受壓的情況下也能保持血管擴張，從而實現更細的支架梁設計。這些更細的支架梁透過減少動脈損傷、改善血流、促進癒合以及最大限度地降低血管再阻塞和血栓症形成的風險，推動了該細分市場的成長。

預計到2025年，北美冠狀動脈支架市佔率將達到39.6%。在美國，由於久坐不動的生活方式、高脂肪飲食和壓力等因素，心血管疾病負擔日益加重，這推動了冠狀動脈支架置入術的需求。該地區先進的醫療基礎設施、專業的冠心病中心和技術精湛的醫務人員使得支架置入術得以廣泛開展。醫院和介入性冠心病中心對創新支架技術的應用，進一步促進了該地區的市場成長。

目錄

第1章：調查方法

  • 研究途徑
  • 品質改進計劃
    • GMI人工智慧政策和資料完整性計劃
      • 資訊來源一致性通訊協定
  • 調查過程和可靠性評分
    • 調查過程的組成部分
    • 評分組成部分
  • 數據收集
    • 主要來源部分列表
  • 資料探勘資訊來源
    • 付費資訊來源
      • 區域資訊來源
  • 基本估算和計算方法
    • 每種方法中基準年的計算
  • 預測模型
    • 量化市場影響分析
      • 生長參數對預測的數學影響
  • 關於調查透明度的補充信息
    • 資訊來源歸屬框架
    • 品質保證指標
    • 對信任的承諾

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 影響產業的因素
    • 促進因素
      • 冠狀動脈疾病盛行率上升
      • 對微創手術的需求日益成長
      • 開發中國家的技術進步
      • 人們對心臟病預防保健的認知和關注度不斷提高
    • 產業潛在風險與挑戰
      • 產品缺陷和召回
      • 嚴格的監管核准
      • 開發中國家缺乏熟練的醫護人員
    • 市場機遇
      • 生物可吸收支架和下一代支架的研發
      • 數位健康與醫學影像技術的融合
  • 成長潛力分析
  • 監理情勢（基於初步調查）
    • 北美洲
    • 歐洲
    • 亞太地區
  • 科技趨勢
    • 當前技術趨勢
    • 新興技術
  • 還款方案（基於初步調查）
  • 未來市場趨勢
  • 價格分析（2025 年）（基於初步調查）
  • 波特五力分析
  • PESTEL 分析
  • 客戶洞察（基於初步研究）
  • Start-Ups場景
  • 人工智慧和生成式人工智慧對市場的影響
  • 投資環境
  • 差距分析

第4章 競爭情勢

  • 介紹
  • 企業矩陣分析
  • 企業市佔率分析（基於初步研究）
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
  • 競爭定位矩陣
  • 主要市場公司的競爭分析
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 業務拓展計劃

第5章 市場估價與預測：依產品分類，2022-2035年

  • 藥物釋放型支架
  • 生物可吸收血管支架（BVS）
  • 裸金屬支架

第6章 市場估計與預測：依類型分類，2022-2035年

  • 球囊式一次性支架
  • 自吸收支架

第7章 市場估計與預測：依材料分類，2022-2035年

  • 鈷鉻合金
  • 不銹鋼
  • 其他材料

第8章 市場估算與預測：依最終用途分類，2022-2035年

  • 心臟中心
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第9章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：公司簡介

  • Abbott
  • Andramed
  • B. Braun
  • Biosensors International Group
  • Biotronik
  • Boston Scientific
  • Cook Medical
  • Elixir Medical
  • GENOSS
  • Medtronic
  • Meril Life Science
  • MicroPort Scientific
  • Sahajanand Laser Technology Limited
  • Stryker
  • Terumo
簡介目錄
Product Code: 2966

The Global Coronary Stents Market was valued at USD 6.7 billion in 2025 and is estimated to grow at a CAGR of 8.2% to reach USD 14.6 billion by 2035.

Coronary Stents Market - IMG1

Market growth is driven by the rising prevalence of cardiovascular diseases, an aging population, advancements in stent technologies, and the increasing adoption of minimally invasive procedures. Coronary stents are tubular devices inserted into narrowed or blocked coronary arteries to maintain vessel patency, enhance blood flow, and prevent heart attacks. The growing incidence of coronary artery disease, a leading cause of mortality worldwide, is fueling demand. Technological innovations such as drug-eluting stents, bioresorbable scaffolds, and polymer-free stents improve long-term outcomes by minimizing restenosis and thrombosis. Rising patient awareness, clinician confidence, and the expansion of revascularization procedures further support adoption. Trends such as the shift toward drug-eluting and biodegradable stents, as well as patient-centric approaches, are shaping industry growth globally.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$6.7 Billion
Forecast Value$14.6 Billion
CAGR8.2%

The drug-eluting stent segment held a share of 84.8% in 2025 owing to its ability to minimize restenosis, enhance long-term patient outcomes, and support minimally invasive interventions. Drug-eluting stents release medication to prevent excessive tissue growth, providing superior long-term results compared to bare-metal stents, which reinforces their widespread clinical adoption.

The cobalt-chromium alloy segment is expected to reach USD 7.5 billion by 2035. Cobalt-chromium stents offer high tensile strength and durability, maintaining vessel expansion under arterial pressure while allowing thinner strut designs. These thinner struts reduce arterial injury, improve blood flow, and accelerate healing, while minimizing the risk of restenosis and thrombosis, driving segment growth.

North America Coronary Stents Market held a 39.6% share in 2025. The U.S. faces a significant burden of cardiovascular diseases, driven by sedentary lifestyles, high-fat diets, and stress, which increases the demand for coronary stent procedures. The region's advanced healthcare infrastructure, specialized cardiac centers, and skilled medical professionals ensure widespread availability of stenting procedures. The adoption of innovative stent technologies across hospitals and interventional cardiology centers further fuels regional growth.

Prominent players in the Global Coronary Stents Market include Abbott, Medtronic, Boston Scientific, Biotronik, MicroPort Scientific, Stryker, Terumo, B. Braun, Biosensors International Group, Cook Medical, GENOSS, Elixir Medical, Andramed, Meril Life Science, and Sahajanand Laser Technology Limited. Companies in the Global Coronary Stents Market are strengthening their positions through continuous research and development to enhance stent safety, performance, and drug delivery capabilities. Firms are expanding their global footprint by entering emerging markets and forging partnerships with hospitals and healthcare providers. They focus on patient-centric and minimally invasive solutions, including bioresorbable and polymer-free stents, while integrating digital monitoring and smart stent technologies. Strategic marketing campaigns, clinician training programs, and collaborations with leading cardiac centers help companies improve adoption, build brand trust, and maintain a competitive edge in the global coronary stents industry.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Type trends
    • 2.2.4 Material trends
    • 2.2.5 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of coronary artery disease
      • 3.2.1.2 Increasing demand for minimally invasive procedures
      • 3.2.1.3 Technological advancement in developing economies
      • 3.2.1.4 Increasing awareness and focus on preventive cardiac care
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Product failure and recall
      • 3.2.2.2 Stringent regulatory approvals
      • 3.2.2.3 Dearth of skilled healthcare professional in developing economies
    • 3.2.3 Market opportunities
      • 3.2.3.1 Development of bioresorbable and next-generation stents
      • 3.2.3.2 Integration of digital health & imaging technologies
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape (Driven by primary research)
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Reimbursement scenario (Driven by primary research)
  • 3.7 Future market trends
  • 3.8 Pricing analysis, 2025 (Driven by primary research)
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis
  • 3.11 Customer insights (Driven by primary research)
  • 3.12 Start-up scenarios
  • 3.13 Impact of AI and generative AI on the market
  • 3.14 Investment landscape
  • 3.15 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis (Driven by primary research)
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Drug eluting stent
  • 5.3 Bioresorbable vascular scaffold (BVS)
  • 5.4 Bare metal stent

Chapter 6 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Balloon expendable stent
  • 6.3 Self-expendable stent

Chapter 7 Market Estimates and Forecast, By Material, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Cobalt-chromium alloy
  • 7.3 Stainless steel
  • 7.4 Other materials

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 Cardiac centers
  • 8.3 Hospitals
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Abbott
  • 10.2 Andramed
  • 10.3 B. Braun
  • 10.4 Biosensors International Group
  • 10.5 Biotronik
  • 10.6 Boston Scientific
  • 10.7 Cook Medical
  • 10.8 Elixir Medical
  • 10.9 GENOSS
  • 10.10 Medtronic
  • 10.11 Meril Life Science
  • 10.12 MicroPort Scientific
  • 10.13 Sahajanand Laser Technology Limited
  • 10.14 Stryker
  • 10.15 Terumo